Literature DB >> 9337186

Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of alpha-adrenergic receptors in ischemic preconditioning.

F Tomai1, F Crea, A Gaspardone, F Versaci, A S Ghini, R De Paulis, L Chiariello, P A Gioffrè.   

Abstract

BACKGROUND: Experimental studies indicate that alpha-adrenergic receptors are involved in ischemic preconditioning. Their role in humans is unknown. METHODS AND
RESULTS: Eighteen patients undergoing angioplasty for an isolated stenosis of the left anterior descending coronary artery were randomized to receive intravenous infusion of phentolamine or placebo during the procedure. Intracoronary ECG and cardiac pain were determined at the end of the first two balloon inflations. Average peak velocity in the contralateral coronary artery during balloon occlusion, an index of collateral recruitment, was also assessed by using a Doppler guide wire. In both phentolamine- and placebo-treated patients, average peak velocity significantly increased from baseline to the end of the first inflation (P<.01), but it did not show any further increase during the second inflation. In phentolamine-treated patients, ST-segment changes and cardiac pain severity during the second inflation were similar to those observed during the first inflation (13+/-9 versus 12+/-8 mm, P=NS, and 51+/-34 versus 54+/-32 mm, P=NS, respectively), whereas in placebo-treated patients, they were significantly less (6+/-4 versus 13+/-7 mm, P<.01, and 26+/-20 versus 49+/-22 mm, P<.05, respectively).
CONCLUSIONS: The adaptation to ischemia observed in humans after two sequential coronary balloon inflations is abolished by phentolamine and is independent of collateral recruitment. Thus, it occurs due to ischemic preconditioning and is, at least in part, mediated by alpha-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337186     DOI: 10.1161/01.cir.96.7.2171

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Chronic therapeutically refractory angina pectoris.

Authors:  Mike J L DeJongste; René A Tio; Robert D Foreman
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

2.  Oral nicorandil recaptures the waned protection from preconditioning in vivo.

Authors:  Efstathios K Iliodromitis; Philip Cokkinos; Anastasia Zoga; Ioulia Steliou; Agathi R Vrettou; Dimitrios Th Kremastinos
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  Antiarrhythmic and anti-ischaemic effects of angina in patients with and without coronary collaterals.

Authors:  R J Edwards; S R Redwood; P D Lambiase; E Tomset; R D Rakhit; M S Marber
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

Review 4.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 5.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

Review 6.  Ischaemic preconditioning and outcomes after angioplasty: effects of drug therapy.

Authors:  Toru Kato; Nobuo Yoshimoto
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Pharmacological modulation of the ATP sensitive potassium channels during repeated coronary occlusions: no effect on myocardial ischaemia or function.

Authors:  T B Lindhardt; N Gadsbøll; H Kelbaek; K Saunamäki; J K Madsen; P Clemmensen; B Hesse; S Haunsø
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

Review 8.  Ischemic preconditioning: protection against myocardial necrosis and apoptosis.

Authors:  Efstathios K Iliodromitis; Antigone Lazou; Dimitrios Th Kremastinos
Journal:  Vasc Health Risk Manag       Date:  2007

Review 9.  The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.

Authors:  Kieran McCafferty; Suzanne Forbes; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  Dis Model Mech       Date:  2014-12       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.